Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine versus valsartan for post-transplant hypertension in renal transplant recipients
ChiCTR-TRC-10001071Phase 4Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amlodipine, valsartan and metoprolol in hypertension (HTN) (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Reduction of blood pressure at 24 weeks. Started Jan 2008; status: completed.
02
Drugs
amlodipinevalsartanmetoprolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-TRC-10001071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001071.